ORGO Oct 2024 5.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.2800

-0.5200

(-18.57%)

As of 02:22PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
With 38% ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) insiders have a lot riding on the company's future
Key Insights Significant insider control over Organogenesis Holdings implies vested interests in company growth 52% of...
GlobeNewswire
Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x
Simply Wall St.
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
Organogenesis Holdings ( NASDAQ:ORGO ) First Quarter 2024 Results Key Financial Results Revenue: US$110.0m (up 2.2...